The Journal of nutrition · 2026
Identification of Circulating Lipidomic Biomarkers of Malnutrition Risk among Oncology Patients in the Total Cancer Care (TCC) Study: A Cross-Sectional Analysis.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Hoobler Rachel, Maschek J Alan, Luo Bai, Murphy E Angela, Kubinak Jason L, Stewart Paul A, Cox James E, Chaix Amandine, Woodruff Kary, Sanchez Alejandro, Coletta Adriana M, Tabung Fred K, Gupta Sumati, Hardikar Sheetal, Colman Howard, Playdon Mary C
Аннотация
BACKGROUND: Early identification of malnutrition is critical for improving clinical outcomes in oncology patients. However, there are no established biomarkers for malnutrition screening.
OBJECTIVES: This study aimed to identify circulating lipid species associated with malnutrition risk among oncology patients through lipidomic analysis.
METHODS: A cross-sectional study was conducted using plasma samples from oncology patients classified as at risk (n = 90) or not at risk (n = 90) for malnutrition using the Malnutrition Screening Tool (Malnutrition Screening Tool score = 0 compared with ≥2). All participants had head and neck, lungs, or gastrointestinal cancer. Targeted lipidomics were conducted using liquid chromatography-mass spectrometry. Elastic net regression adjusted for confounding variables identified lipids associated with malnutrition risk. A weighted lipid malnutrition risk score was derived and evaluated using the receiver operating characteristic area under the curve. Conditional multivariable logistic regression assessed the association of the lipid score with malnutrition risk. Lipid enrichment analysis was performed using the lipid ontology enrichment framework.
RESULTS: Elastic net regression identified 12 lipids species that were inversely associated with malnutrition risk: cholesterol ester 20:0, ceramide 18:2;O2/26:0, lysophosphatidylcholine 26:0/0:0, lysophosphatidylinositol 18:2/0:0, phosphatidylcholine 34:5, phosphatidylcholine 40:8, phosphatidylethanolamine (PE) P-18:0/20:3, PE P-18:1/18:2, PE P-18:1/20:4, sulfated hexosylceramide 18:1;O2/16:0, sphingomyelin 18:2;O2/23:0, and triglyceride (O-50:1). One lipid, dihexosylceramide 18:1;O2/20:0, was positively associated with malnutrition risk. The weighted lipid malnutrition risk score was associated with increased risk for malnutrition [odds ratio: 3.57; 95% confidence interval (CI): 1.97, 6.47, P < 0.001]. Addition of the lipid score to established malnutrition risk factors improved model predictive performance, increasing the receiver operating characteristic area under the curve from 0.78 (95% CI: 0.71, 0.84) to 0.90 (95% CI: 0.86, 0.94). Lipid ontology enrichment analysis indicated downregulation of membrane structure and signaling lipids and upregulation of storage lipids.
CONCLUSIONS: This study highlights the potential of lipidomics to identify biomarkers of malnutrition risk among oncology patients. Large, prospective studies are warranted to validate these findings.
OBJECTIVES: This study aimed to identify circulating lipid species associated with malnutrition risk among oncology patients through lipidomic analysis.
METHODS: A cross-sectional study was conducted using plasma samples from oncology patients classified as at risk (n = 90) or not at risk (n = 90) for malnutrition using the Malnutrition Screening Tool (Malnutrition Screening Tool score = 0 compared with ≥2). All participants had head and neck, lungs, or gastrointestinal cancer. Targeted lipidomics were conducted using liquid chromatography-mass spectrometry. Elastic net regression adjusted for confounding variables identified lipids associated with malnutrition risk. A weighted lipid malnutrition risk score was derived and evaluated using the receiver operating characteristic area under the curve. Conditional multivariable logistic regression assessed the association of the lipid score with malnutrition risk. Lipid enrichment analysis was performed using the lipid ontology enrichment framework.
RESULTS: Elastic net regression identified 12 lipids species that were inversely associated with malnutrition risk: cholesterol ester 20:0, ceramide 18:2;O2/26:0, lysophosphatidylcholine 26:0/0:0, lysophosphatidylinositol 18:2/0:0, phosphatidylcholine 34:5, phosphatidylcholine 40:8, phosphatidylethanolamine (PE) P-18:0/20:3, PE P-18:1/18:2, PE P-18:1/20:4, sulfated hexosylceramide 18:1;O2/16:0, sphingomyelin 18:2;O2/23:0, and triglyceride (O-50:1). One lipid, dihexosylceramide 18:1;O2/20:0, was positively associated with malnutrition risk. The weighted lipid malnutrition risk score was associated with increased risk for malnutrition [odds ratio: 3.57; 95% confidence interval (CI): 1.97, 6.47, P < 0.001]. Addition of the lipid score to established malnutrition risk factors improved model predictive performance, increasing the receiver operating characteristic area under the curve from 0.78 (95% CI: 0.71, 0.84) to 0.90 (95% CI: 0.86, 0.94). Lipid ontology enrichment analysis indicated downregulation of membrane structure and signaling lipids and upregulation of storage lipids.
CONCLUSIONS: This study highlights the potential of lipidomics to identify biomarkers of malnutrition risk among oncology patients. Large, prospective studies are warranted to validate these findings.